Suppressors of cytokine signaling promote Fas-induced apoptosis through downregulation of NF-κB and mitochondrial Bfl-1 in leukemic T cells

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5561-5571

  Oh, Jiyoung ^a,b   Kim, Seol Hee ^a   Ahn, Sinae ^a   Lee, Choong Eun ^a  

^a Sungkyunkwan University   (South Korea)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 RELATED PROTEIN A1; CASPASE 8; DEATH RECEPTOR; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; PROTEIN BID; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING; SYNAPTOPHYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REPORTER GENE; T LYMPHOCYTE; UBIQUITINATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HCT116 CELLS; HUMANS; JURKAT CELLS; MICE; MICE, INBRED BALB C; MITOCHONDRIAL PROTEINS; NF-KAPPA B; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 84871154275     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103415     Document Type: Article

References (51)

1. Arnold, R., D. Brenner, M. Becker, C. R. Frey, and P. H. Krammer. 2006. How T lymphocytes switch between life and death. Eur. J. Immunol. 36: 1654-1658. (Pubitemid 44089031)
2. Xu, G., and Y. Shi. 2007. Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res. 17: 759-771. (Pubitemid 47411431)
3. Zhang, J., X. Xu, and Y. Liu. 2004. Activation-induced cell death in T cells and autoimmunity. Cell. Mol. Immunol. 1: 186-192.
4. Yang, J., P. K. Epling-Burnette, J. S. Painter, J. Zou, F. Bai, S. Wei, and T. P. Loughran, Jr. 2008. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 111: 1610-1616. (Pubitemid 351213452)
5. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in Tcell hybridomas. Nature 373: 441-444.
6. Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579-5588.
7. Luo, X., I. Budihardjo, H. Zou, C. Slaughter, and X. Wang. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490. (Pubitemid 28391864)
8. Gupta, S. 2003. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int. J. Oncol. 22: 15-20.
9. Imamura, R., K. Konaka, N. Matsumoto, M. Hasegawa, M. Fukui, N. Mukaida, T. Kinoshita, and T. Suda. 2004. Fas ligand induces cell-autonomous NF-κB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-α. J. Biol. Chem. 279: 46415-46423. (Pubitemid 39518283)
10. Farley, N., G. Pedraza-Alva, D. Serrano-Gomez, V. Nagaleekar, A. Aronshtam, T. Krahl, T. Thornton, and M. Rincón. 2006. p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells. Mol. Cell. Biol. 26: 2118-2129. (Pubitemid 43346915)
11. Cahill, M. A., M. E. Peter, F. C. Kischkel, A. M. Chinnaiyan, V. M. Dixit, P. H. Krammer, and A. Nordheim. 1996. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene 13: 2087-2096. (Pubitemid 26411558)
12. Guo, Z., M. Zhang, H. An, W. Chen, S. Liu, J. Guo, Y. Yu, and X. Cao. 2003. Fas ligation induces IL-1β-dependent maturation and IL-1β-independent survival of dendritic cells: different roles of ERK and NF-κB signaling pathways. Blood 102: 4441-4447. (Pubitemid 37494108)
13. Micheau, O., S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp. 2001. NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21: 5299-5305. (Pubitemid 32702435)
14. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10: 640-648. (Pubitemid 30354699)
15. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3: 221-227.
16. Weil, R., and A. Israël. 2006. Deciphering the pathway from the TCR to NF-κB. Cell Death Differ. 13: 826-833.
17. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kB. Genes Dev. 18: 2195-2224.
18. Hildeman, D. A., Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16: 759-767. (Pubitemid 34786475)
19. Sandalova, E., C. H. Wei, M. G. Masucci, and V. Levitsky. 2004. Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc. Natl. Acad. Sci. USA 101: 3011-3016. (Pubitemid 38327726)
20. D'Souza, B. N., L. C. Edelstein, P. M. Pegman, S. M. Smith, S. T. Loughran, A. Clarke, A. Mehl, M. Rowe, C. Gélinas, and D. Walls. 2004. Nuclear factor κB-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J. Virol. 78: 1800-1816. (Pubitemid 38176712)
21. Choi, S. S., I. C. Park, J. W. Yun, Y. C. Sung, S. I. Hong, and H. S. Shin. 1995. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698.
22. Zong, W. X., L. C. Edelstein, C. Chen, J. Bash, and C. Gélinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13: 382-387. (Pubitemid 29108753)
23. Busuttil, V., V. Bottero, C. Frelin, V. Imbert, J. E. Ricci, P. Auberger, and J. F. Peyron. 2002. Blocking NF-κB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector. Oncogene 21: 3213-3224. (Pubitemid 34548092)
24. Grumont, R. J., I. J. Rourke, and S. Gerondakis. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13: 400-411. (Pubitemid 29108756)
25. Kim, H., Y. N. Kim, H. Kim, and C. W. Kim. 2005. Oxidative stress attenuates Fas-mediated apoptosis in Jurkat T cell line through Bfl-1 induction. Oncogene 24: 1252-1261. (Pubitemid 40313926)
26. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7: 454-465. (Pubitemid 46834848)
27. Flowers, L. O., H. M. Johnson, M. G. Mujtaba, M. R. Ellis, S. M. Haider, and P. S.Subramaniam. 2004.Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. J. Immunol. 172: 7510-7518. (Pubitemid 38747614)
28. Kamizono, S., T. Hanada, H. Yasukawa, S. Minoguchi, R. Kato, M. Minoguchi, K. Hattori, S. Hatakeyama, M. Yada, S. Morita, et al. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276: 12530-12538.
29. Rui, L., M. Yuan, D. Frantz, S. Shoelson, and M. F. White. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277: 42394-42398. (Pubitemid 35257562)
30. De Sepulveda, P., S. Ilangumaran, and R. Rottapel. 2000. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J. Biol. Chem. 275: 14005-14008. (Pubitemid 30339671)
31. Ryo, A., F. Suizu, Y. Yoshida, K. Perrem, Y. C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, and K. P. Lu. 2003. Regulation of NF- kB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12: 1413-1426. (Pubitemid 38037011)
32. Strebovsky, J., P. Walker, R. Lang, and A. H. Dalpke. 2011. Suppressor of cytokine signaling 1 (SOCS1) limits NFkB signaling by decreasing p65 stability within the cell nucleus. FASEB J. 25: 863-874.
33. Lin, Y. C., C. K. Lin, Y. H. Tsai, H. H. Weng, Y. C. Li, L. You, J. K. Chen, D. M. Jablons, and C. T. Yang. 2010. Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells. Oncol. Rep. 24: 1605-1612.
34. Neuwirt, H., M. Puhr, I. T. Cavarretta, M. Mitterberger, A. Hobisch, and Z. Culig. 2007. Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion. Endocr. Relat. Cancer 14: 1007-1019. (Pubitemid 351252432)
35. Bruun, C., P. E. Heding, S. G. Rønn, H. Frobøse, C. J. Rhodes, T. Mandrup-Poulsen, and N. Billestrup. 2009. Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-α induced apoptosis and signalling in beta cells. Mol. Cell. Endocrinol. 311: 32-38.
36. Kimura, A., T. Naka, S. Nagata, I. Kawase, and T. Kishimoto. 2004. SOCS-1 suppresses TNF-α-induced apoptosis through the regulation of Jak activation. Int. Immunol. 16: 991-999. (Pubitemid 38960877)
37. Yan, L., Q. Tang, D. Shen, S. Peng, Q. Zheng, H. Guo, M. Jiang, and W. Deng. 2008. SOCS-1 inhibits TNF-α-induced cardiomyocyte apoptosis via ERK1/2 pathway activation. Inflammation 31: 180-188.
38. Oh, J., M. W. Hur, and C. E. Lee. 2009. SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis. Oncogene 28: 3145-3156.
39. Naka, T., T. Matsumoto, M. Narazaki, M. Fujimoto, Y. Morita, Y. Ohsawa, H. Saito, T. Nagasawa, Y. Uchiyama, and T. Kishimoto. 1998. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95: 15577-15582. (Pubitemid 29018741)
40. Kim, S. H., and C. E. Lee. 2011. Counter-regulation mechanism of IL-4 and IFN-alpha signal transduction through cytosolic retention of the pY-STAT6:pYSTAT2: p48 complex. Eur. J. Immunol. 41: 461-472.
41. Li, H., H. Zhu, C. J. Xu, and J. Yuan. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501. (Pubitemid 28391865)
42. Werner, A. B., E. de Vries, S. W. G. Tait, I. Bontjer, and J. Borst. 2002. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. J. Biol. Chem. 277: 22781-22788. (Pubitemid 34967258)
43. Keifer, J. A., D. C. Guttridge, B. P. Ashburner, and A. S. Baldwin, Jr. 2001. Inhibition of NF-κB activity by thalidomide through suppression of IkappaB kinase activity. J. Biol. Chem. 276: 22382-22387.
44. Ravi, R., A. Bedi, E. J. Fuchs, and A. Bedi. 1998. CD95 (Fas)-induced caspase-mediated proteolysis of NF-kB. Cancer Res. 58: 882-886. (Pubitemid 28182451)
45. Lee, K. H., K. J. Moon, H. S. Kim, B. C. Yoo, S. Park, H. Lee, S. Kwon, E. S. Lee, and S. Yoon. 2008. Increased cytoplasmic levels of CIS, SOCS1, SOCS2, or SOCS3 are required for nuclear translocation. FEBS Lett. 582: 2319-2324.
46. Baetz, A., C. Koelsche, J. Strebovsky, K. Heeg, and A. H. Dalpke. 2008. Identification of a nuclear localization signal in suppressor of cytokine signaling 1. FASEB J. 22: 4296-4305.
47. Qin, Y., B. Camoretti-Mercado, L. Blokh, C. G. Long, F. D. Ko, and K. J. Hamann. 2002. Fas resistance of leukemic eosinophils is due to activation of NF-κB by Fas ligation. J. Immunol. 169: 3536-3544.
48. Wong, H. K., and G. C. Tsokos. 2006. Fas (CD95) ligation inhibits activation of NF-κB by targeting p65-Rel A in a caspase-dependent manner. Clin. Immunol. 121: 47-53. (Pubitemid 44380408)
49. Chong, M. M. W., A. L. Cornish, R. Darwiche, E. G. Stanley, J. F. Purton, D. I. Godfrey, D. J. Hilton, R. Starr, W. S. Alexander, and T. W. H. Kay. 2003. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 18: 475-487. (Pubitemid 36513630)
50. Kinjyo, I., H. Inoue, S. Hamano, S. Fukuyama, T. Yoshimura, K. Koga, H. Takaki, K. Himeno, G. Takaesu, T. Kobayashi, and A. Yoshimura. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-b1. J. Exp. Med. 203: 1021-1031.
51. Villa-Morales, M., E. González-Gugel, M. N. Shahbazi, J. Santos, and J. Fernández-Piqueras. 2010. Modulation of the Fas-apoptosis- signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility. Carcinogenesis 31: 2165-2171.